Fluence Corporation Limited (EMFGF)
Plymouth, NY, US
Fluence Corporation Limited specializes in delivering comprehensive water and wastewater treatment and reuse solutions for municipal, commercial, and industrial clients worldwide. The company's product offerings include cutting-edge desalination technologies like NIROBOX, which purifies seawater, brackish water, fresh water, and wastewater. They also provide the NIROFLEX series, featuring advanced desalination, ultrafiltration, multimedia filtration, and reverse osmosis systems. For wastewater management, Fluence supplies various products such as Aspiral, an innovative treatment solution; SUBRE membrane aerated biofilm reactor modules; EcoBox systems for water recycling; and Tipton packaged wastewater treatment plants. Furthermore, they offer aeration equipment, including aerators, mixers, and diffusers, alongside dissolved air flotation systems. Beyond water applications, Fluence extends its capabilities to food and beverage processing and recovery, as well as waste-to-energy solutions. Clients also benefit from essential support services, including project financing, the Smart Operations data analytics software, and comprehensive after-sale assistance. Incorporated in 2007, Fluence Corporation Limited is headquartered in White Plains, New York.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +15.33% | -13.00% | +62.24% | -2.38% | -15.74% | +110.91% | +38.92% | -61.33% | -88.95% | -88.95% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Industrial - Pollution & Treatment Controls: +8.0%+57.5% ★ Q4'25: +53.6% (vs Q4'23)
-
EPS growth Industrial - Pollution & Treatment Controls: +15.8%+55.6% ★ Q4'25: +25.0% (vs Q4'23)
-
FCF margin FCF growth · Industrial - Pollution & Treatment Controls: +35.7%+18.3% Q4'25: +11.5% (vs Q4'23)
-
EBIT margin Industrial - Pollution & Treatment Controls: +10.2%-6.5% Q4'25: -6.3% (vs Q4'23)
-
ROIC Industrial - Pollution & Treatment Controls: +6.6%— Q4'25: +134.3% (vs Q4'23)
-
Share dilution Industrial - Pollution & Treatment Controls: 0.0%+1.3% Q4'25: +44.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Pollution & Treatment Controls: -0.39×1.06× Q4'25: 0.25× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
782.7K
est: 360.1K (+117.4%)
|
33.08M
est: 1.54M (+2,047.6%)
|
100.87M
est: 81.66M (+23.5%)
|
60.96M
est: 42.20M (+44.5%)
|
100.71M
est: 74.01M (+36.1%)
|
108.11M
est: 74.80M (+44.5%)
|
119.09M
est: 84.06M (+41.7%)
|
70.04M
est: 47.72M (+46.8%)
|
51.50M
est: 51.50M (0.0%)
|
81.12M
est: 78.40M (+3.5%)
|
86.77M
85.17M – 88.36M
+10.7% YoY
|
87.80M
86.76M – 88.84M
+1.2% YoY
|
108.95M
107.31M – 110.59M
+24.1% YoY
|
| EBITDA |
-8.75M
est: -43.9K (-19,843.9%)
|
-24.36M
est: -187.8K (-12,868.7%)
|
-78.60M
est: -9.96M (-689.5%)
|
-26.15M
est: -5.14M (-408.3%)
|
-2.83M
est: -9.02M (+68.7%)
|
-5.47M
est: -9.12M (+40.0%)
|
-8.70M
est: -10.25M (+15.1%)
|
-8.87M
est: -5.82M (-52.5%)
|
-17.05M
est: -3.68M (-363.7%)
|
18.21M
est: -5.60M (+425.2%)
|
-6.20M
-6.31M – -6.08M
-10.7% YoY
|
-6.27M
-6.34M – -6.20M
-1.2% YoY
|
-7.78M
-7.90M – -7.66M
-24.1% YoY
|
| EBIT |
-9.05M
est: -54.4K (-16,527.5%)
|
-22.79M
est: -233.0K (-9,684.1%)
|
-59.82M
est: -12.35M (-384.4%)
|
-28.60M
est: -6.38M (-348.1%)
|
-7.32M
est: -11.19M (+34.6%)
|
-6.27M
est: -11.31M (+44.6%)
|
-11.06M
est: -12.71M (+13.0%)
|
-10.67M
est: -7.22M (-47.8%)
|
-18.82M
est: -7.71M (-144.2%)
|
-5.25M
est: -11.73M (+55.2%)
|
-12.98M
-13.22M – -12.75M
-10.7% YoY
|
-13.14M
-13.29M – -12.98M
-1.2% YoY
|
-16.30M
-16.55M – -16.06M
-24.1% YoY
|
| Net Income |
-9.06M
est: -35.97M (+74.8%)
|
-23.57M
est: -51.12M (+53.9%)
|
-63.63M
est: -37.86M (-68.0%)
|
-31.59M
est: -39.76M (+20.6%)
|
-19.07M
est: -13.25M (-43.9%)
|
-14.21M
est: -9.47M (-50.1%)
|
-15.92M
est: -3.36M (-374.2%)
|
-16.42M
est: -8.36M (-96.4%)
|
-21.40M
est: -7.07M (-202.7%)
|
-9.64M
est: 386.6K (-2,592.2%)
|
1.25M
1.22M – 1.27M
+222.6% YoY
|
3.28M
3.21M – 3.34M
+162.6% YoY
|
6.55M
6.42M – 6.68M
+100.1% YoY
|
| SGA |
3.90M
est: 107.1K (+3,538.2%)
|
24.24M
est: 458.2K (+5,190.5%)
|
38.00M
est: 24.29M (+56.5%)
|
35.54M
est: 12.55M (+183.2%)
|
25.31M
est: 22.01M (+15.0%)
|
20.75M
est: 22.25M (-6.8%)
|
26.46M
est: 25.00M (+5.8%)
|
29.58M
est: 14.19M (+108.4%)
|
20.56M
est: 16.05M (+28.1%)
|
26.16M
est: 24.43M (+7.1%)
|
27.04M
26.54M – 27.54M
+10.7% YoY
|
27.36M
27.04M – 27.68M
+1.2% YoY
|
33.95M
33.44M – 34.46M
+24.1% YoY
|
| EPS |
-0.04
est: -0.03 (-26.8%)
|
-0.07
est: -0.05 (-55.5%)
|
-0.14
est: -0.04 (-298.8%)
|
-0.05
est: -0.04 (-35.9%)
|
-0.03
est: -0.01 (-118.1%)
|
-0.02
est: -0.01 (-127.9%)
|
-0.02
est: 0.00 (-600.5%)
|
-0.03
est: -0.01 (-296.0%)
|
-0.02
est: -0.01 (-205.8%)
|
-0.01
est: 0.00 (-2,585.9%)
|
0.00
0.00 – 0.00
+222.6% YoY
|
0.00
0.00 – 0.00
+162.6% YoY
|
0.01
0.01 – 0.01
+100.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Benjamin A. Fash | Chief Executive Officer & MD | 476.3K | male |
| Spencer D. Smith | Chief Talent & Legal Officer | 468.5K | male |
| Richard H. Cisterna | Chief Growth Officer | 438.7K | male |
| Osvaldo Llanes | Chief Financial Officer | 325.0K | male |
| Michael Shnitzer | Vice President and Interim GM SEA & China | — | male |
| Natalya Medinina | Vice President & Corporate Controller | — | female |
| Sophia Huang | Associate Company Secretary | — | — |
| Steven Scheidler | Vice President and GM of Municipal Water & Wastewater | — | male |
| Fabio Poletto | Vice President and GM of Industrial Wastewater & Biogas | — | male |
| Manuel Garcia de la Mata | Vice President and GM Industrial Water & Reuse | — | male |
| Melanie Jaye Leydin | Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EMFGF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
